Pulmonary Toxicity of Boron Nitride Nanomaterials Is Aspect Ratio Dependent.

2D materials clearance fibrosis genotoxicity inflammation lungs nanotubes

Journal

ACS nano
ISSN: 1936-086X
Titre abrégé: ACS Nano
Pays: United States
ID NLM: 101313589

Informations de publication

Date de publication:
05 Dec 2023
Historique:
medline: 5 12 2023
pubmed: 5 12 2023
entrez: 5 12 2023
Statut: aheadofprint

Résumé

Boron nitride (BN) nanomaterials have drawn a lot of interest in the material science community. However, extensive research is still needed to thoroughly analyze their safety profiles. Herein, we investigated the pulmonary impact and clearance of two-dimensional hexagonal boron nitride (

Identifiants

pubmed: 38051272
doi: 10.1021/acsnano.3c06599
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Luis Augusto Visani de Luna (LA)

Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9PT, U.K.
National Graphene Institute, The University of Manchester, Manchester, M13 9PL, U.K.
Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9PT, U.K.

Thomas Loret (T)

Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9PT, U.K.
National Graphene Institute, The University of Manchester, Manchester, M13 9PL, U.K.
Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9PT, U.K.

Yilin He (Y)

CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572, University of Strasbourg, ISIS, 67000 Strasbourg, France.

Morgan Legnani (M)

CIRIMAT, Université Toulouse 3 Paul Sabatier, Toulouse INP, CNRS, Université de Toulouse, 118 Route de Narbonne, 31062 Toulouse cedex 9, France.

Hazel Lin (H)

CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572, University of Strasbourg, ISIS, 67000 Strasbourg, France.

Anne Marie Galibert (AM)

CIRIMAT, Université Toulouse 3 Paul Sabatier, Toulouse INP, CNRS, Université de Toulouse, 118 Route de Narbonne, 31062 Toulouse cedex 9, France.

Alexander Fordham (A)

Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9PT, U.K.
National Graphene Institute, The University of Manchester, Manchester, M13 9PL, U.K.
Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9PT, U.K.

Sonja Holme (S)

Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9PT, U.K.
National Graphene Institute, The University of Manchester, Manchester, M13 9PL, U.K.
Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9PT, U.K.

Antonio Esau Del Rio Castillo (AE)

BeDimensional S.p.A., Lungo Torrente Secca 30r, 16163 Genoa, Italy.

Francesco Bonaccorso (F)

BeDimensional S.p.A., Lungo Torrente Secca 30r, 16163 Genoa, Italy.
Istituto Italiano di Tecnologia, Graphene Laboratories, Via Morego 30, 16163 Genoa, Italy.

Alberto Bianco (A)

CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572, University of Strasbourg, ISIS, 67000 Strasbourg, France.

Emmanuel Flahaut (E)

CIRIMAT, Université Toulouse 3 Paul Sabatier, Toulouse INP, CNRS, Université de Toulouse, 118 Route de Narbonne, 31062 Toulouse cedex 9, France.

Kostas Kostarelos (K)

Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9PT, U.K.
National Graphene Institute, The University of Manchester, Manchester, M13 9PL, U.K.
Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST,, Campus UAB, Bellaterra, 08193 Barcelona, Spain.

Cyrill Bussy (C)

Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9PT, U.K.
National Graphene Institute, The University of Manchester, Manchester, M13 9PL, U.K.
Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9PT, U.K.

Classifications MeSH